drugset
Drugs / PfSPZ-GA1 Vaccine
last change Oct 2018 re-read 9 days ago

PfSPZ-GA1 Vaccine

Vaccine

Developed for
malaria
Investigated by
Leiden University Medical Center · Radboud University Medical Center · Sanaria Inc.

Trials 1

today NCT03163121 · Ph 1
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03163121 May 2017 → Oct 2018 malaria Sanaria Inc. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PfSPZ-GA1 Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163121 ↗
Modality Vaccine “PfSPZ-GA1 Vaccine (genetically attenuated PfSPZ)” NCT03163121 ↗
Route Intravenous “direct venous inoculation (DVI)” NCT03163121 ↗